相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses
Yuji Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S. Kariolis et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A Proof-of-Concept Study to Inhibit ABCG2-and ABCB1-Mediated Efflux Transport at the Human Blood-Brain Barrier
Martin Bauer et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
Agessandro Abrahao et al.
NATURE COMMUNICATIONS (2019)
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
Torayuki Okuyama et al.
MOLECULAR THERAPY (2019)
A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
Hiroyuki Sonoda et al.
MOLECULAR THERAPY (2018)
Study of Intraventricular Cerliponase Alfa for CLN2 Disease
Angela Schulz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Roberto Giugliani et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound
Nir Lipsman et al.
NATURE COMMUNICATIONS (2018)
Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS
Noboru Tanaka et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS
Roberto Giugliani et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses
Elsa G. Shapiro et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Correction of central nervous system deficits in the mouse model of Hunter syndrome by recombinant iduronate 2-sulfatase crossing the blood-brain barrier
Hiroyuki Sonoda et al.
MOLECULAR GENETICS AND METABOLISM (2017)
A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
Joseph Muenzer et al.
GENETICS IN MEDICINE (2016)
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
Eric C. Leuthardt et al.
PLOS ONE (2016)
Insulin Receptor Antibody-Iduronate 2-Sulfatase Fusion Protein: Pharmacokinetics, Anti-Drug Antibody, and Safety Pharmacology in Rhesus Monkeys
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Therapeutic Potential of Intracerebroventricular Replacement of Modified Human β-Hexosaminidase B for GM2 Gangliosidosis
Kazuhiko Matsuoka et al.
MOLECULAR THERAPY (2011)
Japan Elaprase (R) Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)
Torayuki Okuyama et al.
MOLECULAR GENETICS AND METABOLISM (2010)
A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
MOLECULAR GENETICS AND METABOLISM (2007)
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
GENETICS IN MEDICINE (2006)
分享论文
